共 15 条
- [1] Johnson R.J., Kang D.H., Feig D., Kivlighn S., Kanellis J., Watanabe S., Et al., Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?, Hypertension, 41, pp. 1183-1190, (2003)
- [2] Cheung A.K., Sarnak M.J., Yan G., Berkoben M., Heyka R., Kaufman A., Et al., HEMO Study Group Cardiac disease in maintenance hemodialysis patients: result of the HEMO study, Kidney Int, 65, pp. 2380-2389, (2004)
- [3] Thurston M.M., Phillips B.B., Bourg C.A., Safety and efficacy of allopurinol in chronic kidney disease, Ann Pharmacother, 47, pp. 1507-1516, (2013)
- [4] Grabowski B.A., Khosravan R., Vernillet L., Mulford D.J., Metabolism and excretion of [14C] febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase, in healthy male subjects, J Clin Pharmacol, 51, pp. 189-201, (2011)
- [5] Faruque L.I., Ehteshami-Afshar A., Wiebe N., Tjosvold L., Homik J., Tonelli M., A systematic review and meta-analysis on the safety and efficacy of febuxostat versus allopurinol in chronic gout, Semin Arthritis Rheum, 43, pp. 367-375, (2013)
- [6] Castrejon I., Toledano E., Rosario M.P., Loza E., Perez-Ruiz F., Carmona L., Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis, Rheumatol Int, 35, pp. 1127-1137, (2015)
- [7] Day R.O., Miners J.O., Birkett D.J., Whitehead A., Naidoo D., Hayes J., Et al., Allopurinol dosage selection: relationships between dose and plasma oxipurinol and urate concentrations and urinary urate excretion, Br J Clin Pharmacol, 26, pp. 423-428, (1988)
- [8] Akimoto T., Morishita Y., Ito C., Iimura O., Tsunematsu S., Watanabe Y., Et al., Febuxostat for hyperuricemia in patients with advanced chronic kidney disease, Drug Target Insights, 13, pp. 39-43, (2014)
- [9] Tsuruta Y., Mochizuki T., Moriyama T., Itabashi M., Takei T., Tsuchiya K., Et al., Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease, Clin Rheumatol, 33, pp. 1643-1648, (2014)
- [10] Kobayashi S., Ogura M., Hosoya T., Acute neutropenia associated with initiation of febuxostat therapy for hyperuricaemia in patients with chronic kidney disease, J Clin Pharm Ther, 33, pp. 258-261, (2013)